Cargando…

Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer

Breast cancer is the most common type of cancer among women worldwide. The Hippo signaling pathway is strongly associated with cell proliferation, migration, invasion, metastasis and resistance to breast cancer treatment. The upstream factors involved in the Hippo signaling pathway, including mammal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yujian, Li, Mengjie, Lin, Jiayi, Hu, Chenxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933775/ https://www.ncbi.nlm.nih.gov/pubmed/33692845 http://dx.doi.org/10.3892/ol.2021.12574

Ejemplares similares

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
por: Holden, Jeffrey K., et al.
Publicado: (2018)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Autopalmitoylation of TEAD Proteins Regulates Transcriptional Output of Hippo Pathway
por: Chan, PuiYee, et al.
Publicado: (2016)

VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
por: Kang, Wei, et al.
Publicado: (2018)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016)

Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming
por: Singh, Vivek P., et al.
Publicado: (2021)

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
por: Lin, Kimberly C., et al.
Publicado: (2017)

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
por: González-Alonso, Paula, et al.
Publicado: (2020)

Leveraging Hot Spots of TEAD–Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling
por: Zhao, Bin, et al.
Publicado: (2023)

VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
por: Xu, Kaicheng, et al.
Publicado: (2020)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Curcumin and Glu-GNPs Induce Radiosensitivity against Breast Cancer Stem-Like Cells
por: Yang, Ke, et al.
Publicado: (2020)

Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
por: of Inflammation, Mediators
Publicado: (2022)

HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway
por: Geng, Hui, et al.
Publicado: (2021)

RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD
por: Unterer, Bea, et al.
Publicado: (2018)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Curcumin Administered in Combination with Glu-GNPs Induces Radiosensitivity in Transplanted Tumor MDA-MB-231-luc Cells in Nude Mice
por: Li, Mengjie, et al.
Publicado: (2021)

The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
por: Al-Mathkour, Marwah M., et al.
Publicado: (2022)

TEAD4 as an Oncogene and a Mitochondrial Modulator
por: Hsu, Sheng-Chieh, et al.
Publicado: (2022)

The role of Hippo signal pathway in breast cancer metastasis
por: Wei, Changran, et al.
Publicado: (2018)

Lipocalin 2: a potential therapeutic target for breast cancer metastasis
por: Hu, Chenxia, et al.
Publicado: (2018)

Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations
por: Troilo, Albino, et al.
Publicado: (2016)

New Therapeutic Approach for Targeting Hippo Signalling Pathway
por: Dominguez-Berrocal, Leticia, et al.
Publicado: (2019)

The relationship between the Hippo signaling pathway and bone metastasis of breast cancer
por: Han, Qinyu, et al.
Publicado: (2023)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

Hippo Signaling Pathway in Gliomas
por: Masliantsev, Konstantin, et al.
Publicado: (2021)

Hippo Signaling Pathway in Pancreas Development
por: Wu, Yifan, et al.
Publicado: (2021)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Hippo signaling pathway and respiratory diseases
por: Tang, Weifeng, et al.
Publicado: (2022)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
por: Juan, Wen Chun, et al.
Publicado: (2016)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_82nqjgl7mt623ksfvb9rqbpa8q